L. Blaszkowsky

发表

"Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer."

Jeffrey W. Clark, K. Lillemoe, A. Zhu, 2017, Annals of surgery.

Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiation.

Jeffrey W. Clark, A. Niemierko, D. Ryan, 2017, Practical radiation oncology.

Case records of the Massachusetts General Hospital. Case 13-2011. A 49-year-old man with adenocarcinoma of the rectum.

M. Blake, J. Lennerz, D. Chung, 2011, The New England journal of medicine.

Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older.

Jeffrey W. Clark, C. Willett, D. Ryan, 2011, International journal of radiation oncology, biology, physics.

Partial abdominal evisceration and intestinal autotransplantation to resect a mesenteric carcinoid tumor

A. Cosimi, L. Blaszkowsky, M. Hertl, 2011, World journal of surgical oncology.

Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma

D. Sahani, B. Rosen, M. Vangel, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer.

A. Zhu, D. Ryan, E. Kwak, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma.

J. Meyerhardt, P. Fidias, J. Temel, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma.

Darrell, Janet, K., 2015, The oncologist.

Mutational and Clinical Predictors of Pathologic Complete Response in the Treatment of Locally Advanced Rectal Cancer

Jeffrey W. Clark, A. Zhu, D. Ryan, 2014, Journal of Gastrointestinal Cancer.

Predictors of adjuvant treatment and survival in patients with intrahepatic cholangiocarcinoma who undergo resection.

K. Lillemoe, A. Zhu, T. Hong, 2019, American journal of surgery.

Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma

K. Lillemoe, M. Qadan, T. Gamblin, 2019, Annals of Surgical Oncology.

Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype

Jeffrey W. Clark, B. Yeap, A. Zhu, 2017, Journal of the National Cancer Institute.

Phase 1/2 study of everolimus in advanced hepatocellular carcinoma

Jeffrey W. Clark, A. Iafrate, J. Meyerhardt, 2011, Cancer.

Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer.

C. Earle, J. Meyerhardt, P. Fidias, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm

Jeffrey W. Clark, R. Nipp, T. Neilan, 2022, PloS one.

The Impact of Pathologic Complete Response in Patients with Neoadjuvantly Treated Locally Advanced Rectal Cancer—a Large Single-Center Experience

D. Berger, Jill N. Allen, L. Blaszkowsky, 2017, Journal of Gastrointestinal Surgery.

A phase II study of gemcitabine, oxaliplatin in combination with bevacizumab (GEMOX-B) in patients with hepatocellular carcinoma

Jeffrey W. Clark, N. Holalkere, D. Sahani, 2005 .

Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or older.

C. Willett, D. Ryan, D. T. Miyamoto, 2008, International journal of radiation oncology, biology, physics.

Care Patterns and Overall Survival in Patients With Early-Onset Metastatic Colorectal Cancer

Jeffrey W. Clark, D. Ryan, T. Hong, 2021, JCO oncology practice.

Pancreatic Neuroendocrine Tumors With Involved Surgical Margins: Prognostic Factors and the Role of Adjuvant

Jeffrey W. Clark, A. Niemierko, C. Willett, 2012 .

Clinical Investigation : Gastrointestinal Cancer Pancreatic Neuroendocrine Tumors With Involved Surgical Margins : Prognostic Factors and the Role of Adjuvant Radiotherapy

Jeffrey W. Clark, A. Niemierko, C. Willett, 2022 .

Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term Outcomes

Jeffrey W. Clark, K. Lillemoe, T. Hong, 2019, Annals of Surgical Oncology.

Primary lymph node gastrinoma: A single institution experience

K. Lillemoe, V. Deshpande, S. Parangi, 2017, Surgery.

A Phase 1b clinical trial of LDE225 (Sonidegib) in combination with fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFIRINOX) in previously untreated locally advanced or metastatic pancreatic adenocarcinoma

D. Ryan, E. Kwak, B. Wolpin, 2021, Annals of Pancreatic Cancer.

Evaluation of the Diagnostic Performance of Positron Emission Tomography/Magnetic Resonance for the Diagnosis of Liver Metastases

A. Soricelli, O. Catalano, L. Umutlu, 2021, Investigative radiology.

Efﬁcacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study

Jeffrey W. Clark, D. Sahani, J. Meyerhardt, 2009 .

Clinical impact of PET/MR in treated colorectal cancer patients

Jeffrey W. Clark, B. Rosen, M. Vangel, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control.

A. Zhu, D. Ryan, E. Kwak, 2014, Practical radiation oncology.

Phase II trial of docetaxel, cisplatin, irinotecan, and bevacizumab in metastatic esophagogastric cancer

L. Sequist, C. Fuchs, A. Hezel, 2008 .

A single-arm trial of panitumumab in cetuximab refractory KRAS wild-type colorectal cancer.

A. Zhu, A. Hezel, D. Ryan, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tolerability and Long-term Outcomes of Dose-Painted Neoadjuvant Chemoradiation to Regions of Vessel Involvement in Borderline or Locally Advanced Pancreatic Cancer

Jeffrey W. Clark, K. Lillemoe, A. Niemierko, 2018, American journal of clinical oncology.

Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastatic colorectal cancer.

C. Earle, J. Meyerhardt, C. Fuchs, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer.

Mari Mino-Kenudson, Giorgio Corti, Mauro Truini, 2016, Cancer discovery.

Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer A C

Jeffrey W. Clark, G. Boland, D. Ryan, 2021 .

Phase I study of neoadjuvant accelerated short course radiation therapy with photons and capecitabine for resectable pancreatic cancer.

K. Lillemoe, D. Ryan, E. Kwak, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Using circulating tumor DNA (ctDNA) to predict surgical outcome and postoperative recurrence following neoadjuvant chemoradiation (CRT) for borderline resectable/locally advanced rectal cancer (LARC).

Jeffrey W. Clark, A. Zhu, D. Ryan, 2019, Journal of Clinical Oncology.

Using circulating tumor DNA (ctDNA) to predict surgical outcome after neoadjuvant chemoradiation for locally advanced pancreatic cancer (LAPC).

Jeffrey W. Clark, K. Lillemoe, A. Zhu, 2018 .

TGF-B1 inhibition with losartan in combination with FOLFIRINOX (F-NOX) in locally advanced pancreatic cancer (LAPC): Preliminary feasibility and R0 resection rates from a prospective phase II study.

Jeffrey W. Clark, K. Lillemoe, Y. Boucher, 2017 .

Pencil Beam Scanning Proton Beam Chemoradiotherapy with 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study.

Jeffrey W. Clark, J. Metz, B. Yeap, 2019, International journal of radiation oncology, biology, physics.

Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529

Jeffrey W. Clark, D. Ryan, E. Kwak, 2017, Advances in radiation oncology.

Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.

D. Ryan, E. Kwak, L. Kachnic, 2010, International journal of radiation oncology, biology, physics.

The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil–Associated Coronary Vasospasm

Jeffrey W. Clark, T. Neilan, V. Raghu, 2021, JACC. CardioOncology.

Dose--volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancer.

Ronald C. Chen, D. Ryan, T. Hong, 2012, International journal of radiation oncology, biology, physics.

A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors.

A. Niemierko, C. Willett, B. Yeap, 2014, Practical radiation oncology.

Phase I/II study of Proton-based Short Course Chemoradiation and Early Surgery for Adenocarcinoma of the Pancreas

B. Yeap, D. Ryan, R. Wadlow, 2010 .

Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer

J. Cusack, T. Hong, M. Qadan, 2021, Diseases of the colon and rectum.

Phase II trial of cabozantinib in patients with carcinoid and pancreatic neuroendocrine tumors (pNET).

J. Meyerhardt, C. Fuchs, A. Zhu, 2017 .

Phase II study of cetuximab in patients with unresectable or metastatic hepatocellular carcinoma.

A. Zhu, P. Enzinger, D. Ryan, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I study of temsirolimus in combination with gemcitabine in previously untreated metastatic pancreatic cancer.

A. Hezel, P. Enzinger, D. Ryan, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Case records of the Massachusetts General Hospital. Case 23-2005. A 57-year-old man with a mass in the liver.

M. Blake, R. Chung, G. Lauwers, 2005, The New England journal of medicine.

Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX

Jeffrey W. Clark, K. Lillemoe, D. Ryan, 2019, Annals of surgery.

Mutational analysis and clinical correlation of metastatic colorectal cancer

A. Iafrate, D. Dias-Santagata, A. Zhu, 2014, Cancer.

Radiation Therapy Enhances Immunotherapy Response in Microsatellite-stable Colorectal and Pancreatic Adenocarcinoma in a Phase II Trial

Jeffrey W. Clark, N. Hacohen, B. Yeap, 2021, Nature Cancer.

Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer

Jeffrey W. Clark, B. Miao, G. Boland, 2021, Clinical Cancer Research.

MDM2 Promoter Polymorphism and Pancreatic Cancer Risk and Prognosis

D. Christiani, R. Heist, A. Zhu, 2008, Clinical Cancer Research.

Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer

W. Goessling, J. Meyerhardt, A. Rustgi, 2023, The oncologist.

Improving staging of rectal cancer in the pelvis: the role of PET/MRI

Jeffrey W. Clark, B. Rosen, A. Soricelli, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial

Jeffrey W. Clark, K. Lillemoe, B. Yeap, 2018, JAMA oncology.

Panitumumab in patients with KRAS wild-type colorectal cancer after progression on cetuximab.

Jeffrey W. Clark, J. Meyerhardt, C. Fuchs, 2012, The oncologist.

A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma.

Jeffrey W. Clark, R. Jain, Y. Boucher, 2014, International journal of radiation oncology, biology, physics.

Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head.

M. Mino‐Kenudson, B. Yeap, D. Ryan, 2011, International journal of radiation oncology, biology, physics.

Pancreatic Ductal Adenocarcinoma: Is There a Survival Difference for R1 Resections Versus Locally Advanced Unresectable Tumors? What Is a “True” R0 Resection?

K. Lillemoe, J. Wargo, D. Ryan, 2013, Annals of surgery.

FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience.

Jeffrey W. Clark, K. Lillemoe, D. Sahani, 2013, The oncologist.

Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers

Jeffrey W. Clark, A. Iafrate, D. Dias-Santagata, 2020, Clinical Cancer Research.

Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

Jeffrey W. Clark, T. Golub, G. Getz, 2019, Nature Medicine.

Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer

Jeffrey W. Clark, A. Zhu, J. Lennerz, 2021, JCO precision oncology.

Response prediction of neoadjuvant chemoradiation therapy in locally advanced rectal cancer using CT-based fractal dimension analysis

A. Kambadakone, Y. Noda, B. Ganeshan, 2021, European Radiology.

Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric Cancers.

Jeffrey W. Clark, A. Iafrate, C. Azzoli, 2020, The oncologist.

Radiation Induced Checkpoint Immunotherapy Response in Refractory Colorectal and Pancreatic Adenocarcinoma

Jeffrey W. Clark, N. Hacohen, B. Yeap, 2020 .

Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis.

Jeffrey W. Clark, A. Zhu, A. Raldow, 2018, Practical radiation oncology.

Refusal of surgery for colon cancer: Sociodemographic disparities and survival implications among US patients with resectable disease.

J. Cusack, M. Qadan, R. Goldstone, 2020, American journal of surgery.

Total Neoadjuvant TherapyWith FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma A Phase 2 Clinical Trial

Jeffrey W. Clark, K. Lillemoe, B. Yeap, 2018 .

Long-Term Outcomes and Prognostic Factors for Patients With Unresectable Locally Advanced Pancreatic Cancer Treated With Intraoperative Radiotherapy at the Massachusetts General Hospital , 1978 to 2010

K. Lillemoe, C. Willett, D. Ryan, 2013 .

Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival.

Jeffrey W. Clark, B. Yeap, A. Zhu, 2019, International journal of radiation oncology, biology, physics.

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Lipika Goyal, Christopher H Crane, Edgar Ben-Josef, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patterns of Care and Outcomes of Definitive External Beam Radiotherapy and Radioembolization for Localized Hepatocellular Carcinoma

A. Niemierko, B. Mahal, A. Zhu, 2019, American journal of clinical oncology.

Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

T. Giordano, A. Benson, M. Soulen, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer.

Jeffrey W. Clark, J. Meyerhardt, C. Fuchs, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical impact of PET/MRI in oligometastatic colorectal cancer

Jeffrey W. Clark, M. Vangel, O. Catalano, 2021, British Journal of Cancer.

Disparities in Receipt of Adjuvant Therapy After Upfront Surgical Resection for Pancreatic Ductal Adenocarcinoma

T. Hong, M. Qadan, L. Blaszkowsky, 2022, Annals of Surgical Oncology.

Impact of PET/MRI in the Treatment of Pancreatic Adenocarcinoma: a Retrospective Cohort Study

Jeffrey W. Clark, M. Vangel, O. Catalano, 2021, Molecular Imaging and Biology.

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer

A. Iafrate, A. Khorana, C. Fuchs, 2014, British Journal of Cancer.

Associations of baseline patient‐reported outcomes with treatment outcomes in advanced gastrointestinal cancer

Jeffrey W. Clark, D. Ryan, N. Horick, 2020, Cancer.

Clinical staging in pancreatic adenocarcinoma underestimates extent of disease.

K. Lillemoe, D. Ryan, T. Hong, 2020, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Evaluation of Pathologic Response on Overall Survival After Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma

K. Lillemoe, T. Hong, M. Qadan, 2020, Pancreas.

Intraoperative Radiotherapy in the Era of Intensive Neoadjuvant Chemotherapy and Chemoradiotherapy for Pancreatic Adenocarcinoma

Jeffrey W. Clark, K. Lillemoe, D. Ryan, 2016, American journal of clinical oncology.

Systematic liquid biopsy identifies novel and heterogeneous mechanisms of acquired resistance in gastrointestinal (GI) cancer patients.

Jeffrey W. Clark, A. Bardelli, A. Zhu, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Chemoradiation-related lymphopenia and its association with survival in patients with squamous cell carcinoma of the anal canal.

Jeffrey W. Clark, D. Ryan, T. Hong, 2020, The oncologist.

Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation.

A. Niemierko, K. Jee, T. Hong, 2015, International journal of radiation oncology, biology, physics.

Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma

Jeffrey W. Clark, J. Meyerhardt, A. Zhu, 2007, Cancer.

Underlying Bias in the Treatment of Pancreatic Cancer

K. Lillemoe, M. Qadan, C. Ferrone, 2021, Annals of surgery.

Proof of concept of the abscopal effect in MSS GI cancers: A phase 2 study of ipilimumab and nivolumab with radiation in metastatic pancreatic and colorectal adenocarcinoma.

B. Yeap, A. Zhu, D. Ryan, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II study of ipilimumab and nivolumab with radiation in metastatic pancreatic adenocarcinoma.

Jeffrey W. Clark, D. Ryan, T. Hong, 2019, Journal of Clinical Oncology.

The γ-Carboxylation Recognition Site Is Sufficient to Direct Vitamin K-dependent Carboxylation on an Adjacent Glutamate-rich Region of Thrombin in a Propeptide-Thrombin Chimera*

B. Furie, B. Furie, J V Ratcliffe, 1997, The Journal of Biological Chemistry.

Superior pathologic and clinical outcomes after minimally invasive rectal cancer resection, compared to open resection

M. Qadan, R. Goldstone, T. Francone, 2019, Surgical Endoscopy.

Socioeconomic determinants of the surgical treatment of colorectal liver metastases.

T. Hong, Hang Lee, M. Qadan, 2020, American journal of surgery.

Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer.

Martin J. Aryee, Linda T. Nieman, Jeffrey W. Clark, 2022, Cancer discovery.

A phase II study of ipilimumab and nivolumab with radiation in microsatellite stable (MSS) metastatic colorectal adenocarcinoma (mCRC).

Jeffrey W. Clark, B. Yeap, A. Zhu, 2019, Journal of Clinical Oncology.

Long‐term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer

Jeffrey W. Clark, A. Niemierko, A. Zhu, 2012, Cancer.

Tolerability, Attrition Rates, and Survival Outcomes of Neoadjuvant FOLFIRINOX for Non-Metastatic Pancreatic Adenocarcinoma: Intent-to-Treat Analysis.

Jeffrey W. Clark, K. Lillemoe, D. Ryan, 2022, Journal of the American College of Surgeons.

Potentially curative combination of TGF-b1 inhibitor losartan and FOLFIRINOX (FFX) for locally advanced pancreatic cancer (LAPC): R0 resection rates and preliminary survival data from a prospective phase II study.

Jeffrey W. Clark, K. Lillemoe, R. Jain, 2018 .

Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis

Jeffrey W. Clark, A. Iafrate, A. Zhu, 2018, Cancer medicine.

Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancer.

A. Niemierko, Jacqueline A. Nyamwanda, D. Ryan, 2015, Practical radiation oncology.

Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Versus the Standard of Care Imaging in the Diagnosis of Peritoneal Carcinomatosis

Jeffrey W. Clark, B. Rosen, O. Catalano, 2022, Annals of surgery.

Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older.

R. Mak, N. Choi, C. Willett, 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

High dose radiation therapy and chemotherapy as induction treatment for Stage III nonsmall cell lung carcinoma

T. Dipetrillo, S. Vora, J. McGrath, 2000, Cancer.

Chemoradiation for localized rectal cancer: Neoadjuvant versus adjuvant approaches

L. Blaszkowsky, 2005 .

Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer.

M. Hidalgo, B. Wolpin, M. Lichinitser, 2013 .

Author Correction: Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

Jeffrey W. Clark, T. Golub, G. Getz, 2019, Nature Medicine.

A multicenter, randomized phase II study of total neoadjuvant therapy (TNT) with FOLFIRINOX (FFX) and SBRT, with or without losartan (L) and nivolumab (N) in borderline resectable (BR) and locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC).

B. Yeap, D. Ryan, D. Ting, 2023, Journal of Clinical Oncology.

Differentiating the pathologies of cerebral malaria by postmortem parasite counts

Wenjiang J. Fu, Ricky T. Tong, Susan Lewallen, 2004, Nature Medicine.

T E C H N I C a L I N N O V a T I O N S Open Access Partial Abdominal Evisceration and Intestinal Autotransplantation to Resect a Mesenteric Carcinoid Tumor

A. Cosimi, L. Blaszkowsky, M. Hertl, 2022 .

Portal Vein or Superior Mesenteric Vein Thrombosis with Dose-Escalated Radiation for Borderline or Locally Advanced Pancreatic Cancer

K. Lillemoe, A. Niemierko, D. Ryan, 2023, Journal of Gastrointestinal Surgery.

Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival.

Jeffrey W. Clark, B. Yeap, A. Zhu, 2019, International journal of radiation oncology, biology, physics.

A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors.

A. Niemierko, C. Willett, B. Yeap, 2014, Practical Radiation Oncology.

Patterns of Care and Outcomes of Definitive External Beam Radiotherapy and Radioembolization for Localized Hepatocellular Carcinoma

A. Niemierko, B. Mahal, A. Zhu, 2019, American journal of clinical oncology.

Mutational analysis and clinical correlation of metastatic colorectal cancer

A. Iafrate, D. Dias-Santagata, A. Zhu, 2014, Cancer.

Clinical impact of PET/MR in treated colorectal cancer patients

Jeffrey W. Clark, B. Rosen, M. Vangel, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation.

A. Niemierko, K. Jee, T. Hong, 2015, International journal of radiation oncology, biology, physics.

Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma

M. Qadan, T. Gamblin, C. Ferrone, 2019, Annals of Surgical Oncology.

Laparoscopic scar: a mimicker of Sister Mary Joseph's nodule on positron emission tomography/CT.

N. Holalkere, A. Fischman, M. Blake, 2006, Australasian radiology.

Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.

K. Lillemoe, E. Kwak, A. Warshaw, 2015, Annals of surgery.

Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer

R. Nipp, A. Mojtahed, A. Parikh, 2023, JAMA network open.

FOLFIRINOX in locally advanced or metastatic pancreatic cancer.

Jeffrey W. Clark, D. Sahani, D. Ryan, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma.

A. Parikh, L. Goyal, C. Eyler, 2024, American journal of clinical oncology.